Font: Financial Modeling Prep • Nov 17, 2026
Humana (NYSE: HUM) is a health insurer whose shares trade at $443.42 when Bernstein SocGen Group raises its price target to $515, putting the share price 16.1% below the target.
The target increase follows a strong run for Humana shares. They rise 11.2% over the past month and reach a new 52-week high of $462.87 in the previous trading session, as highlighted by Zacks Investment Research. The stock gains 80.1% since the start of the year, versus 9% for the Zacks Medical sector and 28.6% for the Zacks Medical - HMOs industry.
Humana beats the Zacks Consensus Estimate in each of the past four quarters. In its November 6 earnings report, the company reports a loss of $0.70 per share, narrower than the estimated loss of $1.03 per share.
Humana plans to launch its national Gold Card program on December 1 to reduce prior authorization requirements and provider paperwork, as highlighted by Business Wire. The program also aims to simplify required authorizations and help patients access care more quickly.
The shares later fall 3.7%, or $17.05, to $444.20. They trade between $431.78 and $447.00, within a 52-week range of $163.11 to $462.87. Humana’s market capitalization is $53.35 billion, with trading volume of 490,509 shares.
|
LICN§>
Lichen International Limited
|
$0.02
-28.18%
|
|
NVDA§>
NVIDIA Corporation
|
$152.11
-2.15%
|
|
CHSN§>
Chanson International Holding
|
$0.10
-78.66%
|
|
SOXL§>
Direxion Daily Semiconductor Bull 3X ETF
|
$49.12
0.09%
|
|
SVRE§>
SaverOne 2014 Ltd
|
$0.75
82.45%
|
|
SPDN§>
Direxion Daily S&P 500 Bear 1X ETF
|
$8.87
0.00%
|
|
INLF§>
INLIF Limited
|
$0.36
0.72%
|
|
AES§>
The AES Corporation
|
$15.02
0.30%
|
|
AKAN§>
Akanda Corp.
|
$3.76
83.41%
|
|
TQQQ§>
ProShares UltraPro QQQ
|
$52.89
2.08%
|